Claims for Patent: 7,883,699

Summary for Patent: 7,883,699

Title:	Methods for enlarging the lumen of an obstructed biological conduit
Abstract:	The invention provides methods to for treating a an obstructed biological conduit that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue. Particular methods include delivery of an enzyme or a mixture of several enzymes to the area or region of obstruction wherein the enzyme(s) have the capability to degrade extracellular matrix components within the obstruction thereby restoring the normal flow of transported fluid through the conduit. The invention also includes prophylactically dilating a section of conduit to minimize the risk of obstruction formation.
Inventor(s):	Franano; F. Nicholas (Kansas City, MO)
Assignee:	Proteon Therapeutics, Inc. (Waltham, MA)
Application Number:	12/229,372
Patent Claims:	1. A method for therapeutically enlarging the lumen of a biological conduit in a mammalian subject in need thereof, wherein said conduit has a lumen that is narrowed by obstructing tissue comprising collagen, said method comprising injecting into said obstructing tissue a pharmaceutically acceptable composition comprising a collagenase in a dose sufficient to solubilize obstructing tissue, whereby said lumen of said conduit is enlarged. 2. The method of claim 1, wherein fluid flow through said conduit is inadequate prior to said treatment. 3. The method of claim 1, wherein said obstruction blocks fluid flow through said conduit prior to said treatment. 4. The method of claim 1, 2 or 3, wherein said mammalian subject is a human. 5. The method of claim 1, wherein said collagenase is a Clostridial collagenase. 6. The method of claim 1, wherein the dose of said collagenase is between 1,000 and 20,000 ABC units. 7. The method of claim 1, wherein said biological conduit is selected from the group consisting of an artery, a vein, a bile duct, a ureter, a pancreatic duct, and a bronchus. 8. The method of claim 1, wherein said composition is administered prior to mechanical dilation of said lumen. 9. The method of claim 1, wherein said composition is administered after mechanical dilation of said lumen. 10. The method of claim 8 or 9, wherein said mechanical dilation is effected by a balloon catheter. 11. The method of claim 1, wherein said administering is performed via a catheter. 12. The method of claim 6, wherein the dose of said collagenase is between 2,500 and 10,000 ABC units. 13. The method of claim 12, wherein the dose of said collagenase is 5,000 ABC units. 14. The method of claim 11, wherein a portion of said catheter is inserted into the obstructing tissue. 15. The method of claim 10, wherein said biological conduit is an artery. 16. The method of claim 15, wherein said mammalian subject is human. 17. The method of claim 16, wherein said obstructing tissue comprises intimal hyperplasia. 18. The method of claim 10, wherein said biological conduit is a vein. 19. The method of claim 18, wherein said mammalian subject is human. 20. The method of claim 19, wherein said obstructing tissue comprises intimal hyperplasia. 21. The method of claim 1-3, 5-13, 8, 9, 11 or 14, wherein said biological conduit is an artery. 22. The method of claim 21, wherein said mammalian subject is human. 23. The method of claim 22, wherein said obstructing tissue comprises intimal hyperplasia. 24. The method of claim 1-3, 5-13, 8, 9, 11 or 14, wherein said biological conduit is a vein. 25. The method of claim 24, wherein said mammalian subject is human. 26. The method of claim 25, wherein said obstructing tissue comprises intimal hyperplasia.

Details for Patent 7,883,699

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2019-09-24